  The prolonged treatment effects of a short-acting GLP-1RA ( glucagon-like peptide-1 receptor agonist) , such as lixisenatide , on fasting and postprandial systemic hemodynamics in type 2 diabetes mellitus patients are unknown. In this secondary analysis , we included 34 overweight insulin glargine-treated type 2 diabetes mellitus patients ( mean ± SD age , 62 ± 7 years; HbA